idarucizumab

English

Etymology

From idaru- (of unknown origin) +‎ -ci- (“cardiovascular”) +‎ -zumab (“humanized monoclonal antibody”).

Pronunciation

• (General American) IPA^(key): /ˌaɪ.də.ɹuˈsɪz.əˌmæb/

Noun

idarucizumab (uncountable)

1. (pharmacology) A monoclonal antibody designed for the reversal of anticoagulant effects of dabigatran.